Mechanisms of Ageing and Development · Nov 14, 2026
GDF-15 and sST2 as independent predictors of long-term mortality in hospitalized older adults: a prospective cohort study
By Giordani C, Di Rosa M, Matacchione G et al.
Growth differentiation factor-15 (GDF-15) and soluble ST2 (sST2) reflect systemic biological stress, inflammation, and aging-related processes, but their prognostic relevance in hospitalized older adults remains unclear. We prospectively studied 966 patients aged ≥65 years from the Report-AGE cohort. Circulating GDF-15 and sST2 were measured at hospital admission, and all-cause mortality was evaluated using Cox proportional hazards models adjusted for demographic characteristics, frailty, comorbidity burden, and routine laboratory parameters. Incremental prognostic value was assessed using likelihood ratio tests, Harrell’s C-index, and time-dependent ROC analyses. Over a median follow-up of 4.2 years, 805 deaths occurred. Higher GDF-15 and sST2 levels independently predicted mortality after multivariable adjustment (GDF-15: HR 1.32, 95% CI 1.17–1.49; sST2: HR 1.24, 95% CI 1.12–1.36; both p<0.001). Each biomarker significantly improved model fit, with additional gains when both were jointly included. Model discrimination improved modestly but consistently over time. In patients with cardiovascular disease, GDF-15 retained incremental prognostic value, whereas that of sST2 was attenuated. Their complementary prognostic information may capture distinct, partially overlapping pathways of biological vulnerability not fully reflected by conventional measures. Overall, combined assessment of GDF-15 and sST2 may improve long-term risk stratification beyond conventional clinical and laboratory markers in hospitalized older adults.
doi.org/10.1016/j.mad.2026.112274Open accessPubMed 43033871Biomarkers